Your browser doesn't support javascript.
loading
Evaluation of changes in intestinal microbiota in Crohn's disease patients after anti-TNF alpha treatment.
Sanchis-Artero, Laura; Martínez-Blanch, Juan Francisco; Manresa-Vera, Sergio; Cortés-Castell, Ernesto; Valls-Gandia, Marina; Iborra, Marisa; Paredes-Arquiola, Jose Maria; Boscá-Watts, Maia; Huguet, Jose Maria; Gil-Borrás, Rafael; Rodríguez-Morales, Josefa; Cortés-Rizo, Xavier.
Affiliation
  • Sanchis-Artero L; Inflammatory Bowel Disease Unit, Department of Digestive Diseases, Sagunto Hospital, Av. Ramón y Cajal S/N, 46520, Sagunto, Valencia, Spain. laurasanchisartero@gmail.com.
  • Martínez-Blanch JF; ADM-Lifesequencing S.L., University of Valencia Science Park, Carrer del Catedràtic Agustín Escardino Benlloch 9, Edificio 2, 46980, Paterna, Valencia, Spain. Juan.MartinezBlanch@adm.com.
  • Manresa-Vera S; Department of preventive medicine, public health, food sciencs, toxicology and forensic medicine, Universitat de Valencia, Valencia, Spain. Juan.MartinezBlanch@adm.com.
  • Cortés-Castell E; ADM-Lifesequencing S.L., University of Valencia Science Park, Carrer del Catedràtic Agustín Escardino Benlloch 9, Edificio 2, 46980, Paterna, Valencia, Spain.
  • Valls-Gandia M; Department of Pharmacology, Pediatrics and Organic Chemistry, Miguel Hernández University, Carretera de Valencia-Alicante S/N, 03550, San Juan de Alicante, Alicante, Spain. ernesto.cortes@umh.es.
  • Iborra M; Inflammatory Bowel Disease Unit, Department of Digestive Diseases, Hospital General de Castellón, Castellón de la Plana, Spain.
  • Paredes-Arquiola JM; Inflammatory Bowel Disease Unit, Department of Digestive Diseases, Hospital Universitario y Politécnico La Fe de Valencia, Valencia, Spain.
  • Boscá-Watts M; Inflammatory Bowel Disease Unit, Department of Digestive Diseases, Hospital Doctor Peset de Valencia, Valencia, Spain.
  • Huguet JM; Inflammatory Bowel Disease Unit, Department of Digestive Diseases, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Gil-Borrás R; Inflammatory Bowel Disease Unit, Department of Digestive Diseases, Hospital General de Valencia, Valencia, Spain.
  • Rodríguez-Morales J; Inflammatory Bowel Disease Unit, Department of Digestive Diseases, Hospital Lluís Alcanyís de Xàtiva, Valencia, Spain.
  • Cortés-Rizo X; Inflammatory Bowel Disease Unit, Department of Digestive Diseases, Sagunto Hospital, Av. Ramón y Cajal S/N, 46520, Sagunto, Valencia, Spain.
Sci Rep ; 11(1): 10016, 2021 05 11.
Article de En | MEDLINE | ID: mdl-33976272
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Crohn / Microbiome gastro-intestinal / Inhibiteurs du facteur de nécrose tumorale Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Sci Rep Année: 2021 Type de document: Article Pays d'affiliation: Espagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Crohn / Microbiome gastro-intestinal / Inhibiteurs du facteur de nécrose tumorale Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: Sci Rep Année: 2021 Type de document: Article Pays d'affiliation: Espagne